Pfizer's share price has almost halved since its 2022 peak and is now down to pre-pandemic 5-year lows. In this analysis, we take a look at why the Pfizer share price is so low and where it may be at the end of the decade. 2030 might sound like a long time into the future, […]
… to continue reading, subscribe to Good Money Guide Analysis to become a better, more informed investor.
Join over 10,000 newsletter subscribers who get our expert, exclusive analysis that provides the sort of information that everyone, from first-time investors to experienced professional traders, can learn to profit from.
- Expert market analysis
- Actionably investing ideas
- Exclusive events & summits
Already subscribed? Login here.